Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19
Simona Tripon, Pascal Bilbault, Thibaut Fabacher, Nicolas Lefèbvre, S. Lescuyer, Emmanuel Andrès, E. Schmitt, Sabrina Kepka, Pierrick Le Borgne, J. Müller, Hamid Merdji, Frédéric Chaffraix, Didier Mutter, Thomas F. Baumert, Ferhat Meziani, Michel Doffoël
Topics & Concepts
MedicineInternal medicineGastroenterologyFatty liverLiver injuryLiver diseaseAlcoholic liver diseaseCoronavirus disease 2019 (COVID-19)FibrosisBilirubinDiseaseGamma-glutamyltransferaseAlkaline phosphataseCirrhosisInfectious disease (medical specialty)BiochemistryEnzymeChemistryCOVID-19 Clinical Research StudiesLiver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry Studies